Aug 10, 2020, 09:50 by

Aug 7, 2020, 09:08 by User Not Found

Clinical Research News | Healthcare systems in five states have reported a decrease in the number of emergency department (ED) visits since April, while hospital admission rates have increased in the same timeframe. A recent study urges public health officials to emphasize the importance of visiting the ED during the COVID-19 pandemic. This, plus more, is included in this week’s announcements and updates from the clinical research industry.

Aug 5, 2020, 15:01 by User Not Found

Clinical Research News | Stand Up To Cancer gets a big pharma investment aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities. And Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories.

Jul 31, 2020, 08:15 by User Not Found

Clinical Research News | Groups of researchers are raising red flags about the quality of COVID-19 clinical trials. A group from Stanford and Yale warned that studies may not be well designed to contribute meaningful clinical evidence. Another group from Johns Hopkins cautioned against overstepping ethical bounds in public health surveillance. Meanwhile, many new trials are launched. 

Jul 30, 2020, 10:01 by User Not Found

Clinical Research News | July was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from John Snow Labs, LabCorp, the FDA, and more.

Jul 29, 2020, 11:12 by

Jul 29, 2020, 11:12 by

Jul 29, 2020, 11:12 by

Alfa Chemistry Testing Lab announced today that it has recently launched customized pharmaceutical analytical services for companies involved with new drug development.

Jul 29, 2020, 11:12 by

Jul 29, 2020, 11:12 by

FHI Clinical announced today a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptive COVID-19 Treatment Trial (ACTT). Supported by the NIAID, part of the NIH, the ongoing ACTT study is a randomized, double-blinded, placebo-controlled trial to allow investigation of putative therapeutics for the treatment of COVID-19 in hospitalized adults.

Jul 29, 2020, 11:10 by

Elligo Health Research®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Jul 29, 2020, 11:10 by

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time.

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

Research Presentation Strategies (RPS), the leader in FDA advisory committee (AdComm) presentation support, announced the use of their technology platform for a successful virtual Cardio-Renal Drug Advisory Committee (CRDAC) meeting that took place on July 15, 2020. The RPS platform was utilized by a sponsor last week for the first fully virtual, day-long drug approval AdComm presentation.

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

Jul 29, 2020, 11:07 by

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.